Aurora Cannabis Stock (NASDAQ:ACB), Trade Ideas

Aurora Cannabis

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements.

matteo-paganelli-MqISkm2iLGc-unsplash(6)

Cannabis

News

CSE:CURA

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

FLGC

TLRY

TSX:ACB

Flora Growth Corp. has entered into a definitive agreement to acquire all of the issued and outstanding shares of Hamburg, Germany-based TruHC Pharma GmbH. The company&#39;s latest move to further cement its global footprint comes on the heels of a new German cannabis law that went into effect on April 1, which partially legalized cannabis. The new law allows adults over 18 in Germany to legally possess up to 25 grams of dried cannabis and cultivate up to three marijuana plants at home.As previously announced, Flora agreed to purchase TruHC Pharma GmbH in an all-stock deal in exchange for 2,770,562 of its common shares, valued at $6.4 million.

Another Cannabis Pioneer Expands In Germany Via Acquisition As Experts Say &#39;There&#39;s No Stepping Back&#39; From Legalization Wave

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

ACOR

ADIL

ASTI

BNRG

BPTS

BSGM

CISS

DCGO

DECK

DOGZ

DXYZ

EZGO

GRRR

ICCT

IFBD

IMRN

JAGX

KITT

MGAM

MRIN

MRNO

NEOV

NOVA

NUTX

OPEN

PRFX

RETO

RVMD

TSLA

VERB

VIAO

VINO

Shares of  Ascent Solar Technologies, Inc. (NASDAQ: ASTI) fell sharply during Wednesday’s session after the company announced pricing of a $6 million public offering of shares at $0.14 per share.

Why Ascent Solar Technologies Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

APLD

FUFU

MNMD

Nuveen California Dividend Advantage Municipal Fund 2

OFLX

RBLX

TSHA

U.S. stocks were lower, with the Dow Jones index falling over 300 points on Wednesday.

Roblox, TAL Education And Other Big Stocks Moving Higher On Wednesday

Aurora Cannabis Inc

Ace Global Business Acquisition Limited - Ordinary Shares

Ace Global Business Acquisition Ltd

Ace Global Business Acquisition Limited - Unit

Ace Global Business Acquisition Limited - Warrant

ALBINA COMMUNITY BNCRP by Albina Community Bancorp

Albina Community Bancorp

Annabidiol Corp

ARCO BIOMEDICAL CO LTD by Acro Biomedical Co., Ltd.

Acro Biomedical Co Ltd

Aurora Cannabis Inc Warrants (31/05/2025)

Former President Donald Trump&#8217;s close allies, including Boris Epshteyn, Mark Meadows, and Rudy Giuliani, have been indicted by an Arizona grand jury. The indictment pertains to their alleged involvement in attempts to overturn the 2020 election results.
What Happened: The Arizona grand jury handed down an indictment against several individuals associated with Trump&#8217;s 2020 campaign. These individuals stand accused of trying to subvert the election results, including the fraudulent electors from Arizona, <a href="https://edition.cnn.com/2024/04/24/politics/arizona-criminal-charges-2020-election-subversion/index.html">reported</a> CNN on Wednesday.
Among the indicted are Epshteyn, a former White House aide and one of Trump&#8217;s closest advisers, former White House chief of staff Meadows, and former New York Mayor Giuliani, as per a source familiar with the investigation, according to CNN .
See Also: <a href="https://www.benzinga.com/general/politics/24/04/38362005/donald-trump-may-soon-receive-36-million-more-djt-shares-key-milestone-ahead?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Donald Trump May Soon Receive An Additional $1.26B In DJT Shares: Key Milestone Ahead (UPDATED)</a>
Arizona Attorney General Kris Mayes announced the indictment on Wednesday night, focusing on the 11 individuals who acted as pro-Trump electors in the state. The names of several other indicted defendants remain redacted until they have been served, Mayes stated.
While Trump himself has not been charged in Arizona, the indictment details suggest he is referred to as &#8220;Unindicted Coconspirator 1&#8221;.
Why It Matters: The indictment of Trump&#8217;s allies in Arizona marks a significant development in the ongoing legal battles surrounding the 2020 election. 
In an interview with Fox News in August 2023, Rep. Marjorie Taylor Greene (R-Ga), a staunch Trump supporter, suggested that the ex-president could potentially <a href="https://www.benzinga.com/news/23/08/33956035/marjorie-taylor-greene-says-donald-trump-may-face-fifth-indictment-in-arizona?itm_source=parsely-api">face a fifth indictment</a>, this time in Arizona, based on a similar alleged fraudulent elector scheme aimed at undermining President Joe Biden&#8217;s narrow victory in the state. 
Image made using photos on Shutterstock
Read Next: <a href="https://www.benzinga.com/news/24/04/38349699/marjorie-taylor-greene-says-mike-johnsons-speakership-is-over-after-house-passes-ukraine-aid-package?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Marjorie Taylor Greene Says Mike Johnson&#8217;s Speakership Is &#8216;Over&#8217; After House Passes Ukraine Aid Package: &#8216;Resign And Allow Us To Move Forward&#8217;</a>
<div style="font-family: 'Lato', sans-serif">
<hr style="border: 0;height: 5px;background: #225aa9" />
<div style="background-color: #f5f5f5;background-position: center;background-size: cover;justify-content: center"></div>

 Engineered by 
 Benzinga Neuro, Edited by 
 
 <a href="None" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none"> 
 Shivdeep Dhaliwal</a> 
 
 
<hr style="border: 0;height: 1px;background: #225aa9" />

 The GPT-4-based Benzinga Neuro content generation system exploits the 
 extensive Benzinga Ecosystem, including native data, APIs, and more to 
 create comprehensive and timely stories for you. 
 <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Learn more.</a>
 
<hr style="border: 0;height: 5px;background: #225aa9" />
 </div>

Politics

General

Trump Allies Giuliani, Meadows Indicted By Arizona Grand Jury For Alleged 2020 Election Subversion — Ex-President Possibly 'Unindicted Co-conspirator 1': Report

APDN

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

WNBA star Brittney Griner is sharing her story for the first time about spending 10 months in a Russian prison in a special edition of 20/20.
In a clip of the emotional interview, Griner shared her experience of having been <a href="https://www.benzinga.com/markets/cannabis/22/03/26007231/breaking-russia-detains-wnba-all-star-brittney-griner-for-alleged-possession-of-hash-oil">arrested and incarcerated</a> after a small amount of cannabis oil was found in her suitcase at a Moscow airport. At the time, Feb. 17, 2022 — just one week before Russia invaded Ukraine — Griner was heading back to Russia where she played for seven years during the off-season from her U.S. team, a center for the Phoenix Mercury.
"I was just so scared for everything because there&#8217;s so much unknown," Griner <a href="https://abcnews.go.com/US/wnba-star-brittney-griner-opens-harrowing-russian-detention/story?id=109495984">told</a> ABC's&nbsp;Robin Roberts,&nbsp;co-anchor of&nbsp;Good Morning America.
Roberts asked Griner what was going on in her mind when she realized that the cannabis cartridges were found in her luggage. Griner, a medical marijuana patient in the U.S., said she realized immediately that her mistake could have devastating consequences.
"My life is over right here," Griner answered. 
Griner admitted that the conditions were so terrible that she had thoughts of ending her life. "The mattress had a huge blood stain on it. I had no soap, no toilet paper. That was the moment where I just felt less than a human," she told Roberts. "I just didn&#8217;t think I could get through what I needed to get through.&#8221;
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="1st look at Brittney Griner&#039;s interview" width="500" height="281" src="https://www.youtube.com/embed/ovmtrgsjwYA?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
When Griner <a href="https://www.benzinga.com/markets/cannabis/22/07/27987966/breaking-brittney-griner-pleads-guilty-biden-lashes-out-over-her-detention-russia-calls-it-hype-">pleaded guilty to drug charges</a> in July 2022, she told a judge in Moscow that she accidentally packed the vape cartridges in her luggage and did not intentionally break Russian law. 
Sentenced to <a href="https://www.benzinga.com/markets/cannabis/22/08/28355539/closing-remarks-in-brittney-griner-case-verdict-and-sentencing-expected-soon">nine years in prison</a> in August, Griner was released on Dec. 8 in a prisoner swap for Russian arms dealer&nbsp;Viktor Bout. But not before being moved to a <a href="https://www.benzinga.com/markets/cannabis/22/11/29642858/brittney-griner-being-moved-to-russian-penal-colony-her-lawyers-dont-yet-know-exact-location">notorious penal colony</a>.
In addition to the exclusive interview, Griner&#8217;s <a href="https://www.benzinga.com/markets/cannabis/23/12/36147628/brittney-griner-will-exclusively-share-her-story-across-multiple-platforms-via-espn-disney-partn">story is the subject of an ESPN documentary</a> and a potential scripted series with ABC detailing her experience.
Photo: Courtesy of ESPN press room

Entertainment

Sports

Global

Media

Brittney Griner Talks For The First Time About Her Russian Detention In Exclusive '20/20' Special

For the first time in more than 130 years, voters will likely choose between two candidates with presidential experience for the <a href="https://www.benzinga.com/topic/2024-election">2024 presidential election.</a>
Here's a look at who voters in swing states currently favor in a 2020 election rematch of Donald Trump and Joe Biden.
What Happened: A close race is expected between Biden and Trump in the 2024 election based on election polls <a href="https://www.benzinga.com/general/sports-betting/24/04/38417836/trump-and-biden-get-ready-2024-election-betting-odds-point-to-major-showdown">and betting odds.</a>
Key demographics like young voters and old voters could play an important role in the election, along with <a href="https://www.benzinga.com/topic/swing-states">key swing states.</a>
A new poll of voters in swing states shows Biden gaining ground over Trump, who has led the way in these key states in recent months.
Here are the results of the recent swing state <a href="https://pro.morningconsult.com/analysis/swing-state-polling-april-2024">poll </a>from Morning Consult for the month of April, with the results from March in parentheses.
Arizona: 49% Trump (48%), 42% Biden (43%)
Georgia: 49% Trump (49%), 43% Biden (42%)
Michigan: 47% Biden (45%), 45% Trump (45%)
Nevada: 51% Trump (46%), 43% Biden (44%)
North Carolina: 51% Trump (49%), 41% Biden (43%)
Pennsylvania: 47% Trump (45%), 46% Biden (45%)
Wisconsin: 48% Trump (45%), 44% Biden (46%)
Related Link: <a href="https://www.benzinga.com/general/politics/24/04/38358680/can-biden-or-trump-build-ikea-furniture-2024-election-polls-may-have-gone-too-far">Can Biden Or Trump Build IKEA Furniture? 2024 Election Polls May Have Gone Too Far</a>
Why It's Important: The new poll shows Trump gaining support in Arizona, Nevada, North Carolina, Pennsylvania and Wisconsin. Trump has some of his biggest leads in Arizona, Nevada and North Carolina since polling began in October 2023 for the swing states.
Biden gained support in Georgia, Michigan and Pennsylvania, but lost support in several states. The key win for the current president is taking a lead in Michigan for the first time since polling began in October.
The new poll also showed Biden gaining voter trust on several items including Medicare and Social Security.
The <a href="https://www.benzinga.com/general/politics/24/03/37884006/trump-vs-biden-key-swing-states-arizona-nevada-michigan-wisconsin-show-close-races-heres-the-rol">seven swing states </a>together represent 93 electoral votes in the 2024 election. Six of the seven swing states were won by Biden in the 2020 election, with Trump winning North Carolina. Five of the seven swing states won by Biden in 2020 flipped from Trump to Biden in the election, including Arizona, Michigan and Wisconsin.
Read Next: <a href="https://www.benzinga.com/general/politics/24/04/38366379/trump-committed-conspiracy-to-undermine-the-integrity-of-a-presidential-election-prosecution-all">Trump Committed &#8216;Conspiracy To Undermine The Integrity Of A Presidential Election,&#8217; Prosecution Alleges In Hush Money Trial</a>
Photo: Shutterstock

Trump Vs. Biden: Former President Dominates Swing States, But Loses One For First Time In New 2024 Election Poll

If you're the parent of a child under 12 and have streaming platform Disney+, there's a good chance you've watched Australian <a href="https://www.benzinga.com/general/entertainment/23/12/36400565/is-disneys-percy-jackson-reboot-a-streaming-sensation-the-impact-of-new-shows-and-blueys-tr">animated hit &#8220;Bluey.</a>&#8220;
The show is turning in big numbers for Walt Disney Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>), but the company also hinted at the show ending or having less content going forward.
What Happened: Streaming platform Disney+, part of the Walt Disney Company, has one of the<a href="https://www.benzinga.com/general/entertainment/24/04/38024244/appletv-a-streaming-winner-new-survey-shows-platform-has-smallest-library-highest-rated-con"> largest content libraries</a> of family-based content, which is a draw to getting adults with children to subscribe to the platform.
Among the hit shows on Disney+ is the Australian show "Bluey," with Disney having the rights in the U.S. The show has drawn praise from kids and from parents, thanks to its relatable storylines.
On April 14, Disney+ aired the episode "The Sign" from the third season of the show. At 28 minutes, the episode was around three times longer than most episodes.
The episode had 10.4 million views globally in its first week on Disney+, <a href="https://www.hollywoodreporter.com/tv/tv-news/bluey-the-sign-ratings-disney-plus-1235879242/">according </a>to The Hollywood Reporter. This ranked as the most-watched episode in the show's history and had the biggest viewership for a Disney Junior show on Disney+.
This episode and its predecessor "Ghostbasket" left fans asking questions about the future as the Heeler family featured on "Bluey" dealt with a potential sale of their home and a move to another city.
Fans were treated to a surprise with the season 3 finale episode appropriately titled, "Surprise."
The episode included a flash forward to main character Bluey as an adult and with a child —&nbsp;leaving more questions about if the show is ending, as many voiced on social media that it felt more like a series finale than a season finale.
Related Link:<a href="https://www.benzinga.com/news/earnings/24/02/36993564/disney-invests-1-5b-in-fortnite-owner-epic-games-in-biggest-ever-gaming-entry-posts-q1-earnings-bea"> Disney Invests $1.5B In Fortnite Owner Epic Games In &#8216;Biggest Ever&#8217; Gaming Entry, Posts Q1 Earnings Beat, Revenue Miss</a>
What's Next: Show creator Joe Brumm told The Hollywood Reporter in 2023 that the BBC, which originally commissioned the show alongside Australia's ABC, to not talk about the kids' voices or the future of the show.&nbsp;
Brumm has also said he's taking a break after the third season, which added to the speculation about the show's future.&nbsp;
A producer of "Bluey" recently confirmed to <a href="https://www.bbc.com/news/entertainment-arts-68795941">BBC </a>that the show will return in the future. Another producer also said it would be a "dream" to make a movie based on Bluey and her family in the future.
"Bluey" debuted on the streaming platform in 2020, becoming one of the most-watched shows in the U.S. on streaming platforms. Data from Nielsen showed the series had an average of 1.19 billion minutes viewed per week across a three-season library of 150 episodes.
The children's show is the most streamed show in the U.S. in 2024 based on viewing time tracked by Nielsen. The show ranked second in 2023 and sixth in 2022.
The show has been a huge hit for Disney and a gap between seasons or an end to the show could eliminate one of the key pieces of content.&nbsp;
In a highly competitive streaming market, platforms need shows like "Bluey" that aren't available other places and are must-watch content for at least one age demographic.
With its appeal to kids and parents alike, "Bluey" hits multiple demographics.
Read Next: <a href="https://www.benzinga.com/general/entertainment/24/03/37701205/taylor-swift-concert-film-hits-streaming-heres-how-to-watch-the-eras-tour-taylors-version">Taylor Swift Concert Film Hits Streaming: Here&#8217;s How To Watch &#8216;The Eras Tour (Taylor&#8217;s Version)&#8217;</a>
Photo: Courtesy Disney+ UK

Bluey Dominates Ratings For Disney+: Kids, Parents Hoping Hit Show Not Over

<h1 class="wp-block-heading">Top Stories for April 24, 2024:</h1>
<ol>
<li>American Battery Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABAT#NASDAQ">ABAT</a>) updated <a href="https://www.benzinga.com/news/24/04/38404516/american-battery-technology-company-publishes-updated-initial-assessment-and-economic-analysis-for-t">its initial assessment</a> for the Tonopah Flats Lithium Project (TFLP).</li>
</ol>
It refined the project&#8217;s scope to use only measured and indicated mineral resources, excluding the more speculative inferred resources.&nbsp;
This strategy improves the project's economics by enhancing access to higher-quality resources and optimizing processing at its newly built demonstration facility. 
Key updates include a 7% reduction in total processed claystone, an 8% increase in lithium grade, a 7% decrease in production costs and a 6% rise in the project&#8217;s net present value to $4.67 billion.
<ol start="2">
<li>Steel Dynamics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STLD#NASDAQ">STLD</a>) reported first-quarter results, with net sales of $4.7 billion and net income of $584 million. </li>
</ol>
Highlights include 3.3 million tons of steel shipments, operating income of $751 million and adjusted EBITDA of $879 million.&nbsp;
The company&#8217;s financial health was further supported by liquidity of $3.1 billion and shareholder returns through $298 million in stock repurchases and an 8% dividend increase.&nbsp;
Demand was solid across sectors, particularly automotive and construction, driving sequential improvements in earnings and operational performance.
Also Read:<a href="https://www.benzinga.com/topic/mining"> </a><a href="https://www.benzinga.com/news/24/04/38390383/copper-prices-approach-2-year-highs-whats-behind-analysts-12-000-price-prediction-for-2026">Copper Prices Approach 2-Year Highs: What&#8217;s Behind Analyst&#8217;s $12,000 Price Prediction For 2026?</a>
<ol start="3">
<li>Gold Royalty Corp (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GROY#AMEX">GROY</a>) entered into a three-year mutual cooperation agreement with Taurus Mining Royalty Fund that allows both parties to co-invest in precious metals royalties and streams. </li>
</ol>
The agreement focuses on assets valued at $30 million or more and provides a framework for identifying and evaluating co-investment opportunities, with the option for each party to invest 25% to 50% in selected transactions.&nbsp;
Additionally, any future sales of interests acquired through this partnership will offer first rights to the other partner.
<ol start="4">
<li>Coeur Mining Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CDE#NYSE">CDE</a>) released its 2023 ESG Report, emphasizing its progress in environmental, social and governance efforts aligned with shareholder value. </li>
</ol>
The report highlights Coeur&#8217;s achievement of the lowest injury rate among peers at 0.46 and its adoption of the Global Industry Standard on Tailings Management (placing it among the top 17% of non-International Council on Mining and Metals companies).
The company also shared its commitment to biodiversity through the Biodiversity Management Standard and advancements in climate resilience, aiming for a 35% reduction in GHG emissions by the end of 2024.
Now Read:<a href="https://www.benzinga.com/"> </a><a href="https://www.benzinga.com/m-a/24/04/38405991/equinox-gold-snaps-up-greenstone-gold-mines-for-995m-in-incredibly-rare-deal">Equinox Gold Snaps Up Greenstone Gold Mines For $995 Million In &#8216;Incredibly Rare&#8217; Deal</a>
Benzinga Mining is the bridge between mining companies and retail investors. Reach out to <a href="mailto:licensing@benzinga.com">licensing@benzinga.com</a> to get connected with the Benzinga community!
Photo: Jose Luis Stephens via Shutterstock.

Commodities

ABAT

GROY

STLD

American Battery Optimizes Lithium Project; Steel Dynamics Reports Q1 Results; Gold Royalty Teams Up With Taurus Mining And More: Wednesday's Top Mining Stories

Helix Energy Solns Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLX#NYSE">HLX</a>) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $0.02 by 250 percent. The company reported quarterly sales of $296.211 million which missed the analyst consensus estimate of $296.725 million by 0.17 percent. This is a 18.44 percent increase over sales of $250.084 million the same period last year.

Earnings

Earnings Misses

Helix Energy Solns Gr Q1 2024 Adj EPS $(0.03) Misses $0.02 Estimate, Sales $296.211M Miss $296.725M Estimate

National Bank Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NBHC#NYSE">NBHC</a>) reported quarterly earnings of $0.82 per share which beat the analyst consensus estimate of $0.76 by 7.89 percent. This is a 22.64 percent decrease over earnings of $1.06 per share from the same period last year. The company reported quarterly sales of $101.724 million which missed the analyst consensus estimate of $103.683 million by 1.89 percent. This is a 7.15 percent decrease over sales of $109.554 million the same period last year.

Earnings Beats

NBHC

National Bank Holdings Q1 2024 GAAP EPS $0.82 Beats $0.76 Estimate, Sales $101.724M Miss $103.683M Estimate

In June 2022, New York Gov. Kathy Hochul announced a deal had finally been reached to <a href="https://www.benzinga.com/markets/cannabis/22/01/24932856/new-york-gov-kathy-hochul-pledges-200m-to-boost-social-equity-efforts-as-part-of-cannabis-legali">fund a $200 million public-private effort</a>, which would finance cannabis dispensaries run by the people who have been the most impacted by the war on drugs.
The much-anticipated public-private fund is now coming under scrutiny following an <a href="https://www.thecity.nyc/2024/04/24/cannabis-fund-social-equity-dispensary/">investigation</a> by THE CITY&#8217;s Rosalind Adams, which uncovered a "lopsided deal" favoring the private equity firm Chicago Atlantic Group and raising concerns about the state's social equity goals. 
The agreement heavily favors Chicago Atlantic, leaving the state exposed to significant risks, noted the outlet.
Even the New York Office of Cannabis Management (OCM) cast doubts on the fund&#8217;s viability according to internal OCM documents that questioned whether the deal had overstated the potential revenue and profit potential.
<h1 class="wp-block-heading">What Happened</h1>
New York state, unable to secure a private equity partner, agreed to a $50 million loan from Chicago Atlantic at a 15% interest rate, with all risk borne by the state.
Critics, including Reinvent Albany, an organization that advocates for government transparency and accountability, deemed the deal to have been detrimental to the state and prospective dispensary owners. Legal experts and consultants likened it to distressed debt lending.
Despite the skepticism and advice against the arrangement, negotiations ultimately led to a secret agreement benefiting Chicago Atlantic.
Previously, THE CITY revealed how cannabis licensees who accept loans from the social equity fund are burdened with high construction costs that they don't control and with interest rates that exceed the state's initial estimates.
"Everyone is worried about defaulting because of the rules and regulations of this loan," said Roland Conner, who runs <a href="https://www.benzinga.com/markets/cannabis/23/01/30496199/ny-gov-hochul-announces-opening-of-first-cannabis-shop-owned-by-person-impacted-by-war-on-drugs">Smacked on Bleecker Street</a> in Greenwich Village, the first legal dispensary owned by a person affected by the drug war.
<h1 class="wp-block-heading">Who's Responsible?</h1>
Details of the deal are still secret, with New York state authorities denying Freedom of Information Law requests. The state comptroller&#8217;s office and key lawmakers say they were not informed or involved in the making of the deal, exposing a shocking lack of oversight.
Meanwhile, Chicago Atlantic secured favorable terms, including leasing rights and a $100 million commitment for property development, raising yet more concerns about profiteering at the expense of marginalized communities.
<h1 class="wp-block-heading">Corruption Or Ineptitude?</h1>
The handling of New York&#8217;s cannabis program seems to reflect a corrosive mix of both ineptitude and potential corruption. While officials may have sought to support marginalized groups, their actions suggest a lack of due diligence and transparency.
One element of the story, which you can read in full <a href="https://www.thecity.nyc/2024/04/24/cannabis-fund-social-equity-dispensary/">here</a>, is that social equity applicants are furious.
A Queens shop owner, Dalessio, who was awarded a retail license designated for people impacted by past drug convictions told THE CITY that after a year of back and forth with the fund, he walked away from the deal.
"It just left such a bad taste in my mouth. I warned everyone I could to stay away from this deal," he said.
Photo: Courtesy of Branding Pot via Shutterstock

Government

Legal

Cannabis Saga In The Empire State: Corruption Or Ineptitude? Private Equity Tramples Social Equity, Report Reveals

Alamos Gold (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGI#NYSE">AGI</a>) reported quarterly Adj earnings of $0.13 per share which met the analyst consensus estimate. The company reported quarterly sales of $277.600 million which beat the analyst consensus estimate of $272.000 million by 2.06 percent. This is a 10.38 percent increase over sales of $251.500 million the same period last year.

Alamos Gold Q1 Adj EPS $0.13, Inline, Sales $277.600M Beat $272.000M Estimate

Piper Sandler analyst Clarke Jeffries maintains Tyler Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TYL#NYSE">TYL</a>) with a Overweight and maintains $520 price target.

Price Target

Analyst Ratings

Piper Sandler Maintains Overweight on Tyler Technologies, Maintains $520 Price Target

Rogers, who will continue to serve as a director of Mativ and will assume the role of Audit Committee Chair.

Management

MATV

Mativ Holdings Appoints Kimberly Ritrievi As Chair Of Board, Succeeding John Rogers

First Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FBMS#NASDAQ">FBMS</a>) reported quarterly earnings of $0.65 per share which beat the analyst consensus estimate of $0.59 by 10.17 percent. This is a 24.42 percent decrease over earnings of $0.86 per share from the same period last year. The company reported quarterly sales of $57.341 million which missed the analyst consensus estimate of $59.927 million by 4.32 percent. This is a 11.68 percent decrease over sales of $64.926 million the same period last year.

FBMS

First Bancshares Q1 2024 Adj EPS $0.65 Beats $0.59 Estimate, Sales $57.341M Miss $59.927M Estimate

Guidance

Veris Residential Raises FY24 Core FFO Per Share Outlook From $0.48-$0.53 To $0.50-$0.54, Est $0.53

Colony Bankcorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBAN#NASDAQ">CBAN</a>) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of $0.31 by 6.45 percent. This is a 6.45 percent increase over earnings of $0.31 per share from the same period last year. The company reported quarterly sales of $28.141 million which beat the analyst consensus estimate of $27.600 million by 1.96 percent. This is a 0.30 percent decrease over sales of $28.227 million the same period last year.

CBAN

Colony Bankcorp Q1 2024 Adj EPS $0.33 Beats $0.31 Estimate, Sales $28.141M Beat $27.600M Estimate

Needham analyst Mike Matson maintains Boston Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>) with a Buy and raises the price target from $71 to $82.

Needham Maintains Buy on Boston Scientific, Raises Price Target to $82

CVB Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVBF#NASDAQ">CVBF</a>) reported quarterly earnings of $0.35 per share which beat the analyst consensus estimate of $0.34 by 2.94 percent. This is a 16.67 percent decrease over earnings of $0.42 per share from the same period last year. The company reported quarterly sales of $126.574 million which beat the analyst consensus estimate of $116.576 million by 8.58 percent. This is a 8.89 percent decrease over sales of $138.930 million the same period last year.

CVBF

CVB Financial Q1 2024 GAAP EPS $0.35 Beats $0.34 Estimate, Sales $126.574M Beat $116.576M Estimate

Bridgewater Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BWB#NASDAQ">BWB</a>) reported quarterly earnings of $0.24 per share which missed the analyst consensus estimate of $0.25 by 4 percent. This is a 35.14 percent decrease over earnings of $0.37 per share from the same period last year. The company reported quarterly sales of $26.181 million which missed the analyst consensus estimate of $27.033 million by 3.15 percent. This is a 13.50 percent decrease over sales of $30.267 million the same period last year.

Bridgewater Bancshares Q1 2024 GAAP EPS $0.24 Misses $0.25 Estimate, Sales $26.181M Miss $27.033M Estimate

U.S. President Joe Biden&#8216;s recent signing of legislation has thrown ByteDance&#8217;s TikTok into the spotlight, with CEO Shou Zi Chew saying <a href="https://www.benzinga.com/news/24/03/38001945/amid-us-china-tussle-tiktok-content-creators-worry-about-bread-and-butter-if-app-ban-succeeds">the platform will fight back.</a>
&#8220;Make no mistake, this is a ban, a ban on TikTok and a ban on you and your voice,&#8221; the CEO said in a two-minute&nbsp;<a href="https://www.tiktok.com/@tiktok/video/7361448925972155679" target="_blank" rel="noreferrer noopener">video</a>&nbsp;posted to TikTok&#8217;s main corporate account.
See Also: <a href="https://www.benzinga.com/news/24/04/38372058/analyst-predicts-tiktok-shutdown-in-us-by-next-year-ahead-of-senate-vote-will-not-operate-here">Analyst Predicts TikTok Shutdown In US By Next Year Ahead Of Senate Vote: &#8216;Will Not Operate Here&#8230;&#8217;</a>
Chew&#8217;s statement, delivered Wednesday, April 24, continued: &#8220;Politicians may say otherwise. But don't get confused. Many who sponsored the bill admit a TikTok ban is their ultimate goal.&#8221;
The legislation, part of a $95 million foreign aid package supporting Israel and Ukraine, was widely supported by the U.S. Senate and the House of Representatives.
It gives ByteDance, TikTok&#8217;s parent company, 270 days to find new owners. If ByteDance fails to comply, TikTok faces removal from Apple Inc&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) and Alphabet Inc&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google app stores in the U.S., People magazine <a href="https://people.com/tiktok-ceo-says-we-arent-going-anywhere-biden-signs-potential-ban-into-law-8638226">reported. </a>
Additionally, there&#8217;s a provision for a three-month extension if a sale is in progress by the initial deadline.
<h1 class="wp-block-heading">ByteDance&#8217;s TikTok Fights Back Against Ban</h1>
TikTok&#8217;s uncertain future stems from discussions that began during the COVID-19 pandemic. Former President Donald Trump initially proposed banning the app in April 2020, a move later paused by the Biden administration in February 2021. Currently, TikTok boasts 170 million American users.
The legislation presents concerns about security, with fears that TikTok could be used for Chinese surveillance or data access. TikTok denies these allegations, and the Chinese government asserts there&#8217;s no evidence supporting claims of national security threats. 
TikTok plans to challenge the legislation, citing freedom of speech. In his video, Chew expressed confidence in their legal fight: &#8220;Rest assured, we aren&#8217;t going anywhere.&#8221; 
&#8220;We are confident and we will keep fighting for your rights in the courts&#8230; The facts and the U.S. Constitution are on our side, and we expect to prevail again,&#8221; he added. 
<h1 class="wp-block-heading">Can I Keep Using TikTok? Exploring The Ban&#8217;s Impact</h1>
Don&#8217;t worry, TikTok won&#8217;t just vanish from your phone overnight.
It&#8217;s likely to be at least a year before any ban takes effect, with potential legal challenges possibly extending the timeline further. While TikTok has succeeded in court before, this marks a new challenge against federal legislation.
Concerning your TikTok app, it&#8217;s unlikely to disappear from your phone immediately. However, if the ban goes into effect it may vanish from Apple and Google&#8217;s app stores, meaning no new downloads, updates, or fixes, as <a href="https://www.nbcnewyork.com/news/national-international/tiktok-ban-us-what-to-know/5350848/#:~:text=No%2C%20TikTok%20will%20not%20suddenly%20disappear%20from%20your%20phone.">per</a> NBC New York. 
Over time, this could pose security risks and usability challenges.
Read Next: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38358239/microsoft-and-oracle-could-be-tiktoks-likely-buyers-but-real-winners-would-be-mark-">Microsoft And Oracle Could Be TikTok&#8217;s &#8216;Likely Buyers,&#8217; But Real Winners Would Be Mark Zuckerberg And Sundar Pichai</a>
Photo: <a href="https://www.shutterstock.com/es/g/salarko">salarko</a> on Shutterstock.

Asia

Regulations

Social Media

AAPL

GOOGL

TikTok Fights Back, 'We Aren't Going Anywhere': What's Next For Users?

Barrington Research analyst James Goss maintains Travelzoo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TZOO#NASDAQ">TZOO</a>) with a Outperform and lowers the price target from $14 to $12.

TZOO

Barrington Research Maintains Outperform on Travelzoo, Lowers Price Target to $12

The head of the U.S. Food and Drug Administration (FDA), Robert Califf, stressed that there's no reason for the Drug Enforcement Administration (DE...

The FDA Supports Cannabis Rescheduling by the DEA

The bad news from Tilray (its Q3 net loss increased by 128%} took a toll last week on the constituents of both the Canadian Cannabis LPs Index and the American Cannabis MSOs Index with all 12 declining by an average of 12%.

Marijuana Stocks Followed The Leader Last Week Tumbling 12%, On Average

Canopy Growth to expedite entry into U.S. cannabis market

Cannabis stocks are mostly down today despite some positive legislative news. Indeed, according to Marijuana Moment, bipartisan discussions are und...

Lawmakers Consider Merging SAFER Banking Act with Crypto Regulation

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
In the world of investing, no single rule needs to be followed. Whether technical, fundamentals, short-term trading or long-term investing, the bottom line is generating returns that consistently beat the index. One strategy that has worked in the last few years to generate quick returns is exposure to short-squeeze stocks.



The idea emerged during the euphoric rally for penny and <a href="https://investorplace.com/stock-types/meme-stocks/">meme stocks</a> in 2021. The underlying logic is considering exposure to stocks where sentiments are overly bearish. The higher the short interest in these stocks, the bigger the likely short-squeeze rally.



IMAC Holdings (NASDAQ:<a href="https://investorplace.com/stock-quotes/back-stock-quote/">BACK</a>) is a good example of my point. The stock has skyrocketed by 225% in the last one month. The short interest in the stock is almost 95%. This column focuses on three stocks with high short interest that are likely to surge in Q2 2024.



Let&rsquo;s discuss the reasons for being positive about these ideas in the coming months.



<h2>Blink Charging (BLNK)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/04/blnk-stock-300x169.jpg" alt="a blink charging station, BLNK stock"><div>Source: David Tonelson/Shutterstock.com</div></div>Blink Charging (NASDAQ:<a href="https://investorplace.com/stock-quotes/blnk)-stock-quote/">BLNK)</a> stock has plunged almost 70% in the last 12 months. The short interest in the stock remains high at 24%. I believe a strong reversal rally is on the cards from deeply oversold levels.



Among the positives, Blink has guided for revenue of $170 million for 2024. At the same time, the company has reaffirmed its guidance to achieve <a href="https://ir.blinkcharging.com/news-events/press-releases/detail/2500/blink-charging-announces-record-fourth-quarter-with-89">positive adjusted EBITDA</a> by December 2024. EBITDA margin expansion will likely sustain in the next few years. The new manufacturing facility in Washington, D.C., will support margin expansion as it enhances the company&rsquo;s vertical integration.



Another note is that the company raised $113 million through its at-the-market offering. The company ended 2023 with a strong cash buffer of $121.7 million.



At the same time, Blink paid off promissory notes and accrued interest of $45.5 million. With a de-levered balance sheet, margin expansion and ample headroom for growth, BLNK stock is attractive at current levels. &nbsp;



<h2>Aurora Cannabis (ACB)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/04/acb_auroracannabis1600-300x169.png" alt="Closeup of mobile phone screen with logo lettering of cannabinoid company Aurora Cannabis (ACB, blurred marijuana leaf (focus on left part of letter R in center)"><div>Source: Ralf Liebhold / Shutterstock.com</div></div>Aurora Cannabis (NASDAQ:<a href="https://investorplace.com/stock-quotes/acb-stock-quote/">ACB</a>) stock has almost remained sideways in the last 12 months. This seems like a good accumulation opportunity. Considering the short interest of 32%, a massive short-squeeze rally is on the cards.



There are two other reasons to believe a breakout is on the cards. First, regulatory headwinds are waning for the cannabis sector. Germany has legalized cannabis and this sets the tone for other European countries. Further, there are calls for the reclassification of cannabis as a Schedule III drug in the U.S. With Presidential elections due later this year, I expect price-action for <a href="https://investorplace.com/industries/healthcare/cannabis/">cannabis stocks</a>.



Further, Aurora Cannabis has shown improvement in key business metrics. As an example, Aurora reported positive adjusted EBITDA for Q3 2024. This was the <a href="https://assets.ctfassets.net/pht0ytxhz9oc/15HkBLxjE30B6jraYMQNol/ab13a5e8857c504f4114731721dab90e/Aurora_IR_supplemental_FY24_Q3_-_FINAL.pdf">fifth consecutive quarter</a> of positive EBITDA. Further, the company has guided for positive free cash flow for the calendar year 2024.



In the last few years, Aurora Cannabis has also focused on deleveraging. With a strong cash buffer, a presence in 15 countries and an expanding EBITDA margin, the outlook for ACB stock is bullish.



<h2>Lucid Group (LCID)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/05/lcid_lucid1600-300x169.png" alt="Lucid Motors (LCID) Air Dream Edition Luxury Electric car and it's technology on display in Lucid (LCID) Studio Showroom"><div>Source: Around the World Photos / Shutterstock.com</div></div>Lucid Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/lcid-stock-quote/">LCID</a>) stock has been on a sustained downtrend. In the last 12 months, LCID stock has plunged by 70%. However, the short interest in the stock remains high at 32%. While I remain bearish on the long-term outlook for the company, I believe that a sharp rally is likely from deeply oversold levels.



It&rsquo;s worth mentioning at the onset that Lucid has disappointed investors. The company was once touted as a Tesla (NASDAQ:<a href="https://investorplace.com/stock-quotes/tsla-stock-quote/">TSLA</a>) competitor. However, business progress has been slow, cash burn has been significant and delivery growth remains unimpressive. It&rsquo;s, therefore, not surprising that investors have punished LCID stock.



In terms of positives, Lucid ended 2023 with a liquidity buffer of $4.78 billion. In March, the company <a href="https://ir.lucidmotors.com/news-releases/news-release-details/lucid-group-inc-announces-investment-10-billion-affiliate-pif">received $1 billion in fund infusion</a> from Ayar Third Investment Company. Therefore, there is ample financial flexibility for investments. It remains to be seen if Lucid can accelerate deliveries in the coming quarters.



On the date of publication, Faisal Humayun did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<div>Faisal Humayun is a senior research analyst with 12 years of industry experience in the field of credit research, equity research and financial modeling. Faisal has authored over 1,500 stock specific articles with focus on the technology, energy and commodities sector.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/04/3-short-squeeze-stocks-to-buy-for-100-returns-in-q2-2024/">3 Short-Squeeze Stocks to Buy for 100% Returns in Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

3 Short-Squeeze Stocks to Buy for 100% Returns in Q2 2024

Canopy Growth, Aurora climb amid SAFER Banking Act push

The SAFER Banking Act, a bill that is designed to allow cannabis businesses to engage with U.S. banks, has a better shot at passing if it's attache...

Analyst: SAFER Banking Act Has 50%-60% Chance of Passing

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
<a href="https://investorplace.com/industries/healthcare/cannabis/">Cannabis stocks</a> may be some of the most controversial investment ideas. But they are also turning out to be one of the most profitable. For example, over the last few weeks, related stocks like Canopy Growth (NASDAQ:<a href="https://investorplace.com/stock-quotes/cgc-stock-quote/">CGC</a>) ran from a low of $2.75 to a high of $11.57. And while CGC recently pulled back to $6, it&rsquo;s just starting to pivot higher again.



All thanks to growing U.S. support for legalization &mdash; with <a href="https://www.pewresearch.org/short-reads/2024/04/10/facts-about-marijuana/">88% of the public</a> believing it should be legal for medicinal and recreational use. <a href="https://www.usnews.com/news/best-states/articles/2024-04-17/cannabis-industry-sees-floridas-weed-referendum-as-potential-game-changer">Florida may soon legalize it for adult use</a>. Germany just made it legal, which could lead to a domino effect across Europe. The U.S. may soon reschedule cannabis from Schedule 1 to 3. Plus, there is growing speculation of positive mentions of legalization heading into the 2024 presidential elections.



All of which could easily send cannabis stocks to higher highs. So, even if you see cannabis stocks as a controversial topic at the moment, it could be one of the most rewarding opportunities. Here are three top ways to trade the potential green boom today.



<h2>Innovative Industrial Properties (IIPR)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/aurora-cannabis-stock-7-300x169.jpg" alt="A close-up shot of a marijuana growhouse. cannabis trends"><div>Source: Shutterstock</div></div>One of the best ways to trade the cannabis boom &mdash; and collect yield &mdash; is with Innovative Industrial Properties (NYSE:<a href="https://investorplace.com/stock-quotes/iipr-stock-quote/">IIPR</a>). For one, it is technically oversold at $94.23, and starting to pivot higher. Two, it carries a safe yield of 7.73% at the moment. The company also just paid out its latest dividend of $1.82 on Apr. 15, with more on the way.



Recent earnings were solid, too. Fourth quarter funds from operations (FFO) was $2.07, beating expectations for $2.02. Revenue of $79.2 million was also above estimates for $76.5 million. That&rsquo;s also up nicely from the $70.5 million posted a year ago. It also collected 100% rent in the quarter as compared to 97% in the prior quarter.&nbsp;



In addition, <a href="https://investorplace.com/2024/04/dank-dividends-3-cannabis-reits-offering-high-yields/">as I noted on Apr. 15</a>, &ldquo;One of its key catalysts should be cannabis rescheduling. The moment this happens, it could cut taxes for cannabis operators, which includes IIPR tenants, which would also help improve overall cash flow.&rdquo;



<h2>Trulieve Cannabis (TCNNF)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/05/tcnnf-stock-1600-300x169.jpg" alt="Florida licensed medical marijuana cannabis provider Trulieve"><div>Source: Leigh Trail / Shutterstock.com</div></div>Investors may also want to use the weakness in Trulieve Cannabis&nbsp;(OTCKMKTS:<a href="https://investorplace.com/stock-quotes/tcnnf-stock-quote/">TCNNF</a>) as an opportunity, too. Now trading at $10.74, I&rsquo;d like to see it retest $13.75 initially.&nbsp;



If Florida approves adult-use legalization, Trulieve could benefit significantly. In fact, &ldquo;If passed, the possession of up to three ounces of cannabis will be legal for adults as early as May 2025, transforming the state&rsquo;s&nbsp;medical marijuana&nbsp;market, estimated to generate $2 billion in annual sales,&rdquo;&nbsp;<a href="https://seekingalpha.com/news/4087333-trulieve-led-florida-cannabis-campaign-gathers-steam">says Seeking Alpha</a>.



That would be big news for TCNNF. Plus, as noted by ClickOrlando.com, &ldquo;According to campaign finance data from the Florida Division of Elections, Trulieve almost solely funded the $40 million dollars spent to help push the initiative.&rdquo;



Helping,&nbsp;<a href="https://www.tipranks.com/news/the-fly/trulieve-best-positioned-for-florida-adult-use-vote-says-alliance-global">Alliance Global Partners also noted TCNNF is best positioned</a>&nbsp;after the recent decision from the Florida State Supreme Court.&nbsp;And while revenue fell about 7% year over year to $1.13 billion in 2023, the company generated $202 million in cash flow from operations and $161 million in free cash flow. It also increased its retail footprint to 192 locations across the country.



<h2>Aurora Cannabis (ACB)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/04/acb_auroracannabis1600-300x169.png" alt="Closeup of mobile phone screen with logo lettering of cannabinoid company Aurora Cannabis (ACB, blurred marijuana leaf (focus on left part of letter R in center)"><div>Source: Ralf Liebhold / Shutterstock.com</div></div>Since bottoming out at around $3 in March, Aurora Cannabis (NASDAQ:<a href="https://investorplace.com/stock-quotes/acb-stock-quote/">ACB</a>) hit a high of $8.88. Now back to $6.46, it could push higher as it nears the Florida vote on potential legalization. It&rsquo;s also pushing higher on news the &ldquo;National Conference of State Legislatures sent a letter to Congress urging that the bipartisan SAFER Banking Act be attached to the Federal&nbsp;Aviation Administration reauthorization bill to help speed passage,&rdquo; <a href="https://seekingalpha.com/news/4091168-canopy-growth-aurora-climb-amid-safer-banking-act-push">as noted by Seeking Alpha</a>.



In addition, <a href="https://www.sec.gov/Archives/edgar/data/1683541/000127956924000123/ex991.htm">according to CEO Miguel Martin</a>, &ldquo;Fiscal 2024 is on track to be our strongest to date, driven by the continued strength of our differentiated business model and our focus on profitable global medical cannabis markets. Q3 marks our fifth consecutive quarter of positive adjusted EBITDA, driven by consistent performance in our Canadian business and substantial revenue growth internationally. We are now on the cusp of achieving positive adjusted EBITDA&nbsp;on an annualized basis for the first time in fiscal 2024.&rdquo;



On the date of publication, Ian Cooper did not hold (either directly or indirectly) any positions in the securities mentioned. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines.</a>
<div>Ian Cooper, a contributor to InvestorPlace.com, has been analyzing stocks and options for web-based advisories since 1999.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/04/want-more-green-buy-these-3-red-hot-cannabis-stocks-today/">Want More Green? Buy These 3 Red-Hot Cannabis Stocks Today.</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Want More Green? Buy These 3 Red-Hot Cannabis Stocks Today.

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Marijuana legalization may be inching closer in the U.S. but it <a href="https://www.cnn.com/2024/04/01/europe/germany-cannabis-legalization-day-scli-intl/index.html#">just became a reality</a> in Germany. As of April 1, Germans can now legally grow up to three marijuana plants for personal use. They can also possess up to 50 grams at home and up to 25 grams in public.&nbsp;



Starting July 1, people will be able to buy marijuana at not-for-profit clubs. The clubs will be limited to 500 people and members can only consume the cannabis the club sells. Marijuana will still be illegal for minors, around schools and near playgrounds.



Because Germany is Europe&rsquo;s largest economy, marijuana legalization will set the tone for other countries expected to follow its lead. Cannabis companies are ready to capitalize on the opportunity but some are ready to hit the ground running. That&rsquo;s because they already have a presence in Germany providing medical marijuana, which has been legal since 2017.



For that reason, the following three <a href="https://investorplace.com/industries/healthcare/cannabis/">cannabis stocks</a> stand positioned for an early lead. But pot stock investors should still be cautious. Canada&rsquo;s marijuana legalization efforts <a href="https://investorplace.com/2023/08/3-cannabis-stocks-with-dividends-worth-rolling-into-your-portfolio/">showed just how royally screwed up</a> the government can make the opportunity.



<h2>Tilray Brands (TLRY)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2023/08/tlry1600-300x169.png" alt="In this photo illustration, the Tilray Brands (TLRY) logo is displayed on a smartphone screen"><div>Source: rafapress / Shutterstock.com</div></div>Tilray Brands (NASDAQ:<a href="https://investorplace.com/stock-quotes/tlry-stock-quote/">TLRY</a>) is arguably the best-positioned cannabis stock in Germany. Its European offices are headquartered in Berlin and the company has operated in the country since 2016. It currently serves the German medical marijuana market, which is the largest in Europe. 



Even more exciting, Tilray has the <a href="https://seekingalpha.com/article/4682962-tilray-brands-inc-tlry-q3-2024-earnings-call-transcript">largest market share by revenue</a> of any marijuana company in Germany and already has a sales team on the ground. Its distribution arm, CC Pharma (also known as Tilray Pharma) can distribute medical marijuana to 13,000 pharmacies in the country. Tilray also has production facilities in Portugal and Canada and exports marijuana to Germany. 



Tilray projects a fivefold increase in marijuana cultivation under legalization leading to revenues doubling. TLRY stock jumped from $1.60 per share ahead of legalization to around $3 per share afterward. But it immediately crashed again and now trades below $1.80 per share. As the best cannabis stock to buy for German legalization, this is a good deal.



In short, Tilray is the No. 1 cannabis stock because it has all the infrastructure in place. Though personal marijuana consumption grabs the headlines, the medical marijuana market is still a real opportunity.&nbsp;



<h2>Canopy Growth (CGC)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/04/cgc-1600-1-300x169.png" alt="Closeup of mobile phone screen with logo lettering of cannabinoid company canopy growth cannabis, blurred marijuana in the background. CGC stock."><div>Source: Ralf Liebhold / Shutterstock</div></div>Once one of the biggest cannabis stocks after Canada&rsquo;s legalization, Canopy Growth (NASDAQ:<a href="https://investorplace.com/stock-quotes/cgc-stock-quote/">CGC</a>) has fallen to a middling size with a $722 million valuation. It stands ready, however, to enjoy significant growth from Germany where it has operated for years.



Like Tilray, it supplies the medical marijuana market and will benefit from many of the same forces that will push its rival higher. Canopy, though, has just as good of a chance of winning in the personal use space, which can multiply the leverage legalization provides.



Canopy Growth acquired the global leader in vaporizers, Storz &amp; Bickel, in 2018. Its <a href="https://internationalcbc.com/the-top-cannabis-firms-in-germany-in-2024/">Volcano device is hailed</a> as &ldquo;one of the greatest cannabis consumption devices on earth&rdquo; by the International Cannabis Business Conference. Its manufacturing facility is located in Tuttlingen, Germany. Canopy generated <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001737927/000095017023029420/cgc-20230331.htm">$64.8 million in revenue</a> from Storz &amp; Bickel in fiscal year 2023 with gross margins of 40%. In the third quarter of fiscal 2024, the brand generated $18.5 million in sales, down slightly from the year-ago period but up 54% sequentially. It also posted gross margins of 51% as a new vaporizer product, Venty, had the <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1737927/000095017024013050/cgc-20240209.htm">most successful product launch</a> in the brand&rsquo;s 20-year history.



<h2>Aurora Cannabis (ACB)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/aurora-cannabis-stock-300x169.jpg" alt="Partial view of Aurora Cannabis (ACB) logo in green"><div>Source: ElRoi / Shutterstock.com</div></div>The third cannabis stock poised to pop on Germany&rsquo;s legalization law is Aurora Cannabis (NASDAQ:<a href="https://investorplace.com/stock-quotes/acb-stock-quote/">ACB</a>). It is one of the three companies with marijuana cultivation permission in Germany. &nbsp;Aurora also owns state-of-the-art production facilities in Germany that have received good manufacturing practices (GMP) certifications from European regulators. It can produce 1,000 kilograms of medical marijuana annually.&nbsp;



Aurora prides itself on the <a href="https://www.sec.gov/Archives/edgar/data/1683541/000168354123000007/a997-aif.htm">new cultivars it develops</a>, pointing specifically to the Farm Gas and Sourdough flower cultivars that deliver super-high quality tetrahydrocannabinol (THC) to the medical marijuana market in Germany and Australia. Its Pedanios brand is one of the leading medical cannabis brands.



While it will benefit from legalization in Germany through the expansion of the medical marijuana opportunity like the others, Aurora Cannabis has a firm foothold across Europe. As more countries follow Germany&rsquo;s lead, the cannabis stock stands to benefit from its long-established presence as it was one of the first Canadian marijuana companies to position itself on the continent.



On the date of publication, Rich Duprey did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com <a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/">Publishing Guidelines</a>.
<div>Rich Duprey has written about stocks and investing for the past 20 years. His articles have appeared on Nasdaq.com, The Motley Fool, and Yahoo! Finance, and he has been referenced by U.S. and international publications, including MarketWatch, Financial Times, Forbes, Fast Company, USA Today, Milwaukee Journal Sentinel, Cheddar News, The Boston Globe, L&rsquo;Express, and numerous other news outlets.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/04/cashing-in-on-cannabis-why-these-3-weed-stocks-are-primed-to-pop/">Cashing in on Cannabis: Why These 3 Weed Stocks Are Primed to Pop</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Cashing in on Cannabis: Why These 3 Weed Stocks Are Primed to Pop

Aurora Cannabis: Improved Financials, Limited Opportunity

AYRWF

BACK

BLNK

CRLBF

CRON

GTBIF

IIPR

LCID

SNDL

TCNNF

TSNDF

VRNOF

Press Releases

Aurora Completes Final Repayment of Convertible Senior Notes Representing ~$465 Million in Total Repayments Since 2021; Cannabis Operations Are Now Debt Free[1]